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Appendix A 
Preparation of Solutions 
 
TLC Analysis (Visualizing Reagents) 
i) Preparation of Dragendorff’s Reagent 
This reagent was used to detect the presence of alkaloid compound by orange 
spot would be visible on the TLC plate after sprayed with the reagent. 
Procedure: 
Solution A : A 1.7 gram bismuth nitrate in 100 ml mixture of water-acetic acid, 
H2O-HOAc (80:20) 
Solution B : A 40 gram of potassium iodide in 100 ml distilled water. 
The reagent was prepared by mixing 5 ml solution A with 5 ml solution B 
together with 20 ml of acetic acid and 70 ml of distilled water into reagent 
bottle. 
 
ii) Preparation of Vanillin-Sulphuric Acid Reagent 
This reagent was used to detect the presence of terpenoid and phenol 
derivatives. Purple and pink/red coloured spots would be visible on the TLC 
plates after sprayed and heated to 110 °C. Purple colour indicated the presence 
of various terpenoid derivatives while pink/red colour indicated phenol 
derivatives. 
Procedure: 
The reagent was prepared by adding 1 gram vanillin to 100 ml absolute ethanol 
with 1.5 ml concentrated sulphuric acid into reagent bottle. 
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iii) Preparation of Anisaldehyde-Sulphuric Acid Reagent 
This reagent was used to detect flavanoid derivatives. Purple coloured spots will 
be visible on the TLC plates after sprayed and heated to 110 °C. Purple colour 
indicated the presence of various flavanoid derivatives. 
Procedure: 
The reagent was prepared by adding 10 ml of acetic acid glycial to 0.5 ml of 
anysaldehyde followed by adding 85 ml of methanol and 5 ml concentrated 
sulphuric acid into reagent bottle. 
 
iv) Preparation of Iodine Vapour 
This iodine vapour was used to detect conjugated compound by brownish colour 
appeared after exposed to the iodine in closed tank. 
Procedure: 
The iodine in solid form was bought ready-made from supplier. The iodine was 
put into closed tank together with TLC plate and let the iodine evaporated.  
 
  Total Phenolic Content (TPC) 
 
i) Preparation of Folin-ciocalteu 
A folin-ciocalteu reagent was diluted to 10 fold of distilled water. 
Procedure: 
A 2 ml of folin-ciocalteu reagent was pipetted in measuring cylinder 
containing 18 ml distilled water. 
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ii) Preparation of 6% (w/v) sodium carbonate 
A stock of 1.2 g sodium carbonate was dissolved in 20 ml distilled water. 
Procedure:  
A 1.2 g of sodium carbonate powder was weighted using a balance. The 
sodium carbonate powder was poured into a graduated cylinder containing 18 
ml of distilled water. Once the sodium carbonate was dissolved completely 
(swirls the cylinder gently if necessary), distilled water was added to bring the 
volume up to the final volume of 20 ml. 
 
iii) Preparation of 0.05 mg/ml standard gallic acid 
A stock of 0.0005 g gallic acid was dissolved in 10 ml distilled water. The 
stock solution was kept in centrifuge tube and wrapped with aluminium foil.  
Procedure: 
A 0.0005 g of gallic acid powder was weighted using a balance. The gallic 
acid powder was poured into a graduated cylinder containing 8 ml of distilled 
water. Once the gallic acid was dissolved completely (swirls the cylinder 
gently if necessary), distilled water was added to bring the volume up to the 
final volume of 10 ml. 
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Antioxidant Assays 
 
(I) 2,2-Diphenyl-1-picryl-hydrazyl (DPPH) Free Radical Scavenging Activity Assay 
i) Preparation of 1 mg/ml Ascorbic Acid 
A stock of 0.01 g of ascorbic acid was dissolved in 10 ml methanol. The stock 
solution was kept in universal bottle and wrapped with aluminium foil. 
Procedure: 
A 0.01 g of ascorbic acid powder was weighted using a balance. The ascorbic 
acid powder was poured into a graduated cylinder containing 8 ml of 
methanol. Once the ascorbic acid was dissolved completely (swirls the 
cylinder gently if necessary), methanol was added to bring the volume up to 
the final volume of 10 ml. 
  
ii) Preparation of 1mM DPPH 
A stock of 0.00394 g of DPPH (Sigma) was dissolved in 10 ml methanol. The 
stock solution was kept in universal bottle and wrapped with aluminium foil. 
Procedure: 
A 0.00394 g of DPPH powder was weighted using a balance. The DPPH 
powder was poured into a graduated cylinder containing 8 ml of methanol. 
Once the DPPH was dissolved completely (swirls the cylinder gently if 
necessary), methanol was added to bring the volume up to the final volume of 
10 ml. (MW=394.32 g/ml) 
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(II) Reducing Power Assay 
i)        Preparation of 1% (10 mg/ml) potassium ferricyanide [K3Fe(CN)6] 
A stock of 0.6 g of potassium ferricyanide was dissolved in 60 ml distilled 
water. The stock solution was kept in centrifuge tube and wrapped with 
aluminium foil. 
Procedure: 
A 0.6 g of potassium ferricyanide was weighted using a balance. The 
potassium ferricyanide powder was poured into a graduated cylinder 
containing 55 ml of distilled water. Once the potassium ferricyanide was 
dissolved completely (swirls the cylinder gently if necessary), distilled water 
was added to bring the volume up to the final volume of 60 ml. 
 
ii) Preparation of 10% (100 mg/ml) Trichloroacetic acid (TCA) 
A stock of 6 g of trichloroacetic acid was dissolved in 60 ml distilled water. 
The stock solution was kept in centrifuge tube and wrapped with aluminium 
foil. 
Procedure: 
A 6 g of trichloroacetic acid crystal was weighted using a balance. The 
trichloroacetic acid crystal was poured into a graduated cylinder containing 55 
ml of distilled water. Once the trichloroacetic acid was dissolved completely 
(swirls the cylinder gently if necessary), distilled water was added to bring the 
volume up to the final volume of 60 ml. 
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iii) Preparation of 0.1 % (1mg/ml) ferric chloride (FeCl3) 
A stock of 0.01 g of ferric chloride was dissolved in 10 ml distilled water. The 
stock solution was kept in centrifuge tube and wrapped with aluminium foil. 
Procedure: 
A 0.01 g of ferric chloride crystal was weighted using a balance. The ferric 
chloride crystal was poured into a graduated cylinder containing 8 ml of 
distilled water. Once the ferric chloride was dissolved completely (swirls the 
cylinder gently if necessary), distilled water was added to bring the volume up 
to the final volume of 10 ml. 
 
(III) Metal Chelating Assay 
 
i)        Preparation of 5mM of Ferrozine (MW: 492.45) 
A stock of 0.0246 g of ferrozine was dissolved in 10 ml deionized water. The 
stock solution was kept in centrifuge tube and wrapped with aluminium foil. 
Procedure: 
A 0.0246 g of ferrozine powder was weighted using a balance. The ferrozine 
powder was poured into a graduated cylinder containing 8 ml of deionized 
water. Once the ferrozine was dissolved completely (swirls the cylinder gently 
if necessary), deionized water was added to bring the volume up to the final 
volume of 10 ml. 
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ii) Preparation of 2mM Ferum Chloride (FeCl2) – (MW:198.81)  
A stock of 0.0025 g of ferum chloride was dissolved in 10 ml deionized water. 
The stock solution was kept in centrifuge tube and wrapped with aluminium 
foil. 
Procedure: 
A 0.0025 g of ferum chloride was weighted using a balance. The ferum 
chloride was poured into a graduated cylinder containing 8 ml of deionized 
water. Once the ferum chloride was dissolved completely (swirls the cylinder 
gently if necessary), deionized water was added to bring the volume up to the 
final volume of 10 ml. 
 
iii) Preparation of 1 mg/ml Ethylenediaminetetraacetic acid (EDTA) 
A stock of 0.01 g of EDTA was dissolved in 10 ml deionized water. The stock 
solution was kept in centrifuge tube and wrapped with aluminium foil. 
Procedure: 
A 0.01 g of EDTA was weighted using a balance. The EDTA was poured into 
a graduated cylinder containing 4 ml of distilled water. The pH was adjusted 
to pH 8 while stirring with Sodium Hydroxide (NaOH) solution until most of 
EDTA dissolved. Once the EDTA dissolved, total volume of the solution was 
added with deionized water until the final volume of 10 ml.  
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(IV)  Haemolysate Catalytic Assay 
 
i)        Preparation of haemolysate 
A stock of haemolysate was prepared in 500 ml of scott bottle and kept in ice 
at 4°C. The haemolysate stock was freshly prepared every time used. 
Procedure: 
 A 250 µl blood from vacutainer tube was added into scott bottle containing 
500 ml distilled water using P1000 micropipetter.  
 
ii) Preparation of 1 M hydrogen peroxide (H2O2)  
A 10 ml of 1 M hydrogen peroxide was prepared in universal bottle and kept 
in ice at 4°C. The hydrogen peroxide stock used was freshly prepared. 
Procedure: 
A 910 µl of 35 % 11 M hydrogen peroxide was poured in graduated cylinder 
containing a little less than 9090 µl of distilled water. After that, more 
distilled water was added to bring final volume of solution up to 1000 µl in 
order to eliminate any error because the final volume of the solution may not 
equal the calculated sum of the individual components. 
 
iii) Preparation of 0.1 M sodium azide 
 A stock of 0.006501 g of sodium azide was dissolved in 10 ml distilled water. 
The stock solution was kept in universal bottle. 
Procedure: 
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A 0.006501 g of sodium azide powder was weighted using a balance. The 
sodium azide powder was poured into a graduated cylinder containing 8 ml of 
distilled water. Once the sodium azide was dissolved completely (swirls the 
cylinder gently if necessary), distilled water was added to bring the volume up 
to the final volume of 10 ml. 
 
Antimicrobial Assays 
 
i)     Preparation of Mueller Hinton Agar (Difco TM) 
Procedure:  
A 38 gram of the powder was suspended in 1 liter of purified or sterile water 
and was mixed thoroughly. The solution was heated with frequent agitation and 
boiled for 1 minute to completely dissolve the powder before autoclaved at 121 
°C for 15 minutes. The agar media was cool to room temperature followed by 
pouring into sterile petri dishes on a level pouring surface to a uniform depth of 
4 mm and allowed it to solidify.  
 
ii)      Preparation of Mueller Hinton Broth (Difco TM) 
Procedure:  
A 22 gram of the powder was suspended in 1 liter of purified or sterile water 
and was mixed thoroughly. The solution was heated with frequent agitation and 
boiled for 1 minute to completely dissolve the powder before autoclaved at 121 
°C for 10 minutes. The broth media was cool to room temperature followed by 
pouring into sterile bijou bottle or universal bottle. 
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iii)      Preparation of Nutrient Agar (Difco TM) 
Procedure:  
A 23 gram of the powder was suspended in 1 liter of purified or sterile water 
and was mixed thoroughly. The solution was heated with frequent agitation and 
boiled for 1 minute to completely dissolve the powder before autoclaved at 121 
°C for 15 minutes. The agar media was cool to room temperature followed by 
pouring into sterile petri dishes on a level pouring surface to a uniform depth of 
4 mm. 
 
iv)      Preparation of Nutrient Broth (Difco TM)  
Procedure:  
A 8 gram of the powder was suspended in 1 liter of purified or sterile water and 
was mixed thoroughly. The solution was heated with frequent agitation and 
boiled for 1 minute to completely dissolve the powder before autoclaved at 121 
°C for 15 minutes. The broth media was cool to room temperature followed by 
pouring into sterile bijou bottle or universal bottle. 
 
v)      Preparation of Sabouraud Dextrose Agar (Difco TM) 
Procedure:  
A 65 gram of the powder was suspended in 1 liter of purified or sterile water 
and was mixed thoroughly. The solution was heated with frequent agitation and 
boiled for 1 minute to completely dissolve the powder before autoclaved at 121 
°C for 15 minutes. The agar media was cool to room temperature followed by 
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pouring into sterile petri dishes on a level pouring surface to a uniform depth of 
4 mm and allowed it to solidify.  
 
vi)      Preparation of Tryptic Soy Agar (Difco TM) 
Procedure:  
A 40 gram of the powder was suspended in 1 liter of purified or sterile water 
and was mixed thoroughly. The solution was heated with frequent agitation and 
boiled for 1 minute to completely dissolve the powder before autoclaved at 121 
°C for 15 minutes. The agar media was cool to room temperature followed by 
pouring into sterile petri dishes on a level pouring surface to a uniform depth of 
4 mm and allowed it to solidify.  
 
vii)      Preparation of Tryptic Soy Broth (Difco TM) 
Procedure:  
A 30 gram of the powder was suspended in 1 liter of purified or sterile water 
and was mixed thoroughly. The solution was heated with frequent agitation and 
boiled for 1 minute to completely dissolve the powder before autoclaved at 121 
°C for 15 minutes. The broth media was cool to room temperature followed by 
pouring into sterile bijou bottle or universal bottle. 
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Appendix B 
Antimicrobial Assay (Paper Disc Diffusion Method) 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
Inhibition zone diameter of Ervatamia coronaria (stems) chloroform extract against 
Moraxella catarrhalis 
 
 
 
   
Inhibition zone diameter of Ervatamia coronaria (stems) methanol extract against 
Moraxella catarrhalis 
Negative control 
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Appendix C 
Publication / Conference / Expo 
 
 
APPENDIX 
 
268 
 
Abstract in Innovation and Creativity Expo (University Malaya) 
 
 
 
 
 
 
 
 
 
 
 
 
APPENDIX 
 
269 
 
 
 
 
 
APPENDIX 
 
270 
 
Abstract in 46
th
 MSPTM Annual Scientific Conference 
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Abstract in The 11
th
 Symposium of the Malaysian Society of Applied Biology 
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Abstract in 1st AMDI International Biohealth Science Conference (IBSC) 
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Abstract in 15
th 
Biological Sciences Graduate Congress 
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Abstract in Malaysian Society of Pharmacology and Physiology 
 
 
